Li Xingyao, An Peng, Zhao Yanhong, Cai Zimo, Ye Bingyu, Wang Yafeng, Wang Wenfang, Gao Qi, Li Liuyun, Zhang Tao, Wu Xili
Department of Integrated Chinese Traditional and Western Medicine, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Department of Rheumatism, Xi'an Fifth Hospital, Xi'an 710082, China.
Evid Based Complement Alternat Med. 2022 Apr 22;2022:3664696. doi: 10.1155/2022/3664696. eCollection 2022.
Mesangial proliferative glomerulonephritis (MesPGN) is a common renal disease that lacks effective drug intervention. Aconiti Lateralis Radix (Fuzi), a natural Chinese medical herb, is found with significant therapeutic effects on various diseases in the clinic. However, its effects on MesPGN have not been reported. This study is aimed to discuss the therapeutic effects of the aqueous extract of Aconiti Lateralis Radix (ALR) and the polysaccharides of Aconiti Lateralis Radix (PALR) on MesPGN as well as the underlying mechanism. In this study, we, firstly, studied the anti-MesPGN mechanism of ALR and PALR. ALR and PALR inhibit the proliferation of the mesangial cells through the PI3K/AKT/mTOR pathway, induce the G0/G1 phase of block and apoptosis, inhibit the activity of Cyclin E and CDK2, increase the expression of Bax, cleaved caspase-8/caspase-8, and cleaved caspase-3/caspase-3 proteins, and effectively inhibit the growth of the mesangial cells. Overall, our data suggest that ALR and PALR may be potential candidates for MesPGN and that PALR is more effective than ALR.
系膜增生性肾小球肾炎(MesPGN)是一种缺乏有效药物干预的常见肾脏疾病。附子,一种天然的中药材,在临床上对多种疾病具有显著的治疗作用。然而,其对MesPGN的影响尚未见报道。本研究旨在探讨附子水提取物(ALR)和附子多糖(PALR)对MesPGN的治疗作用及其潜在机制。在本研究中,我们首先研究了ALR和PALR抗MesPGN的机制。ALR和PALR通过PI3K/AKT/mTOR途径抑制系膜细胞的增殖,诱导G0/G1期阻滞和凋亡,抑制Cyclin E和CDK2的活性,增加Bax、裂解的caspase-8/caspase-8和裂解的caspase-3/caspase-3蛋白的表达,并有效抑制系膜细胞的生长。总体而言,我们的数据表明ALR和PALR可能是治疗MesPGN的潜在候选药物,且PALR比ALR更有效。